UCB U.S. News | UCB

UCB's Global Corporate Website

Welcome to UCB in the United States

Healthcare Professionals

Categories

Archives

2026
- February
2025
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2024
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2023
- December
- November
- October
- September
- August
- July
- June
- April
- March
- February
- January
2022
- December
- November
- September
- August
- June
- May
- March
- February
- January
2021
- December
- November
- October
- September
- August
- May
- April
- February

Dec

08

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder

Read More

Dec

04

UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting

Read More

Dec

03

Bridging Strategy and Innovation: Leadership in Action through the AES BRIDGE Program

Read More

Choose a Country